These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24828199)

  • 1. Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
    Raghu D; Karunagaran D
    J Nat Prod; 2014 May; 77(5):1130-4. PubMed ID: 24828199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emodin suppresses Wnt signaling in human colorectal cancer cells SW480 and SW620.
    Pooja T; Karunagaran D
    Eur J Pharmacol; 2014 Nov; 742():55-64. PubMed ID: 25205133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Wnt signaling activity for growth suppression induced by quercetin in 4T1 murine mammary cancer cells.
    Kim H; Seo EM; Sharma AR; Ganbold B; Park J; Sharma G; Kang YH; Song DK; Lee SS; Nam JS
    Int J Oncol; 2013 Oct; 43(4):1319-25. PubMed ID: 23900432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo.
    Hsu YL; Cho CY; Kuo PL; Huang YT; Lin CC
    J Pharmacol Exp Ther; 2006 Aug; 318(2):484-94. PubMed ID: 16632641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The organochlorine p,p'-dichlorodiphenyltrichloroethane induces colorectal cancer growth through Wnt/β-catenin signaling.
    Song L; Zhao J; Jin X; Li Z; Newton IP; Liu W; Xiao H; Zhao M
    Toxicol Lett; 2014 Aug; 229(1):284-91. PubMed ID: 24968063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt/β-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells.
    Kang YJ; Park HJ; Chung HJ; Min HY; Park EJ; Lee MA; Shin Y; Lee SK
    Mol Pharmacol; 2012 Aug; 82(2):168-77. PubMed ID: 22550094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory mechanisms of two Uncaria tomentosa extracts affecting the Wnt-signaling pathway.
    Gurrola-Díaz CM; García-López PM; Gulewicz K; Pilarski R; Dihlmann S
    Phytomedicine; 2011 Jun; 18(8-9):683-90. PubMed ID: 21156346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of 2-hydroxycinnamaldehyde for human colon cancer cells through suppression of β-catenin signaling.
    Lee MA; Park HJ; Chung HJ; Kim WK; Lee SK
    J Nat Prod; 2013 Jul; 76(7):1278-84. PubMed ID: 23855266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-29b downregulates canonical Wnt signaling by suppressing coactivators of β-catenin in human colorectal cancer cells.
    Subramanian M; Rao SR; Thacker P; Chatterjee S; Karunagaran D
    J Cell Biochem; 2014 Nov; 115(11):1974-84. PubMed ID: 24913975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of 5-aminosalicylic acid on the progression of colorectal adenomas via the β-catenin signaling pathway.
    Munding J; Ziebarth W; Pox CP; Ladigan S; Reiser M; Hüppe D; Brand L; Schmiegel W; Tannapfel A; Reinacher-Schick AC
    Carcinogenesis; 2012 Mar; 33(3):637-43. PubMed ID: 22198215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lawsone derivatives target the Wnt/β-catenin signaling pathway in multidrug-resistant acute lymphoblastic leukemia cells.
    Hamdoun S; Fleischer E; Klinger A; Efferth T
    Biochem Pharmacol; 2017 Dec; 146():63-73. PubMed ID: 29061340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of FBXL20 in human colorectal adenocarcinoma.
    Zhu J; Li K; Dong L; Chen Y
    Oncol Rep; 2012 Dec; 28(6):2290-8. PubMed ID: 23023584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging.
    Yeh CT; Rao YK; Ye M; Wu WS; Chang TC; Wang LS; Wu CH; Wu AT; Tzeng YM
    Toxicol Appl Pharmacol; 2012 May; 261(1):31-41. PubMed ID: 22465936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both Wnt and mTOR signaling pathways are involved in insulin-stimulated proto-oncogene expression in intestinal cells.
    Sun J; Jin T
    Cell Signal; 2008 Jan; 20(1):219-29. PubMed ID: 17993259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC.
    Voorneveld PW; Kodach LL; Jacobs RJ; van Noesel CJ; Peppelenbosch MP; Korkmaz KS; Molendijk I; Dekker E; Morreau H; van Pelt GW; Tollenaar RA; Mesker W; Hawinkels LJ; Paauwe M; Verspaget HW; Geraets DT; Hommes DW; Offerhaus GJ; van den Brink GR; Ten Dijke P; Hardwick JC
    Br J Cancer; 2015 Jan; 112(1):122-30. PubMed ID: 25393365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
    Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
    Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.